Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial
Author:
Publisher
Wiley
Subject
Ophthalmology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2008.01265.x/fullpdf
Reference41 articles.
1. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy;Abelson;Surv Ophthalmol,1993
2. Differential diagnosis of ocular allergic disorders;Abelson;Ann Allergy,1993
3. Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis;Abelson;Clin Ther,2004
4. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate;Aguilar;Acta Ophthalmol Scand,2000
5. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal conjunctivitis;Akman;Eye,1998
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Allergic Conjunctivitis Management: Update on Ophthalmic Solutions;Current Allergy and Asthma Reports;2024-06-13
2. Anti-edematous effects of epinastine, cetirizine and its enantiomers in ?,-carrageenan-induced edema in rat hind paw;PHARMAZIE;2024
3. Comparison of ketotifen with olopatadine for allergic conjunctivitis: A meta-analysis study;Revue Française d'Allergologie;2023-10
4. A COMPARATIVE STUDY OF OLOPATADINE 0.01% COMBINED FLUOROMETHOLONE 0.1% TREATMENT VERSUS OLOPATADINE 0.01% COMBINED KETOROLAC 0.4% TREATMENT IN ALLERGIC CONJUNCTIVITIS IN SAROJINI DEVI EYE HOSPITAL;International Journal of Pharmacy and Pharmaceutical Sciences;2023-10-01
5. Topical ketotifen treatment for allergic conjunctivitis: a systematic review and Meta-analysis;International Journal of Ophthalmology;2023-02-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3